Video
Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.
The Aesthetic Society Year in Review 2023/2024
Related Articles
Biostimulators and energy-based devices are increasingly used in combination to address visible signs of aging.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
The recent Facial and Rhinoplasty Symposium was a tremendous success – and a great example of how The Society is evolving to meet the needs of our members and the demands of a fast-changing industry.
The dues support the 30+ ongoing studies that have been funded by The Foundation including studies such as “Cytotoxicity of Implant-Exposed Serum on Breast Cancer”, “Impact of Xeomin, Dysport, and Botox on Nerve Injuries”, “Effect of Intramuscular Fat Grafting on New Muscle Formation”, “Does TXA reduce Bruising After Hyaluronic Acid Filler Injection: A Prospective half face study”, “Increasing SMAS Durability via Photochemical Passivation for Facelifts”, and “Histologic Effects of Energy-Based Skin Tightening Treatments”.
In this update, Dr. Pfeifer talks about the upcoming program planning for Aesthetic Interactive: Facial & Rhinoplasty Symposium in Boca Raton, Florida, and The Aesthetic MEET in Boston, Massachusetts, recapping the May Master Class with Dr. Calobrace, and her upcoming trips to Monaco, New England, and Singapore!